Stay updated on Cobimetinib Combo vs. Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Cobimetinib Combo vs. Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Cobimetinib Combo vs. Pembrolizumab in Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check23 days agoChange DetectedA site-wide notice about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” appears near the top of the page.SummaryDifference0.5%

- Check30 days agoChange DetectedThe site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check37 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1. The study record information remains unchanged.SummaryDifference0.1%

- Check57 days agoChange DetectedAdded the revision tag 'Revision: v3.7.0' to the study history and removed the previous tag 'Revision: v3.6.6', indicating an update to the page's version history.SummaryDifference0.1%

- Check78 days agoChange DetectedA new revision entry labeled v3.6.6 was added to the study record history, and the previous v3.6.5 entry was removed. This reflects an update to the record’s version in the history.SummaryDifference0.1%

Stay in the know with updates to Cobimetinib Combo vs. Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cobimetinib Combo vs. Pembrolizumab in Melanoma Clinical Trial page.